DreamozTech

  Negev Labs – Breakthrough Neurotherapies, 4x NAV Growth   Investment Highlights Sector : Biotech/Neuroplasticity – Addressing multi-billion-dollar opportunities in cognitive and emotional health Business Model:  Venture builder model, focused on B2B partnerships, spin-outs, and licensing strategies Board and Management Track Record:  Led by a team with deep expertise in biopharma innovation, neuroplasticity research, and successful company building Clients:  Two proto-companies, Ariadne Bio (Parkinson’s) and Athena Neurosciences (ADHD), launching in 2025 Shareholders:  Over 60% of the current $7M raise already secured by professional investors Traction Metrics:  Deployed $5M across seven programs, achieving a net asset valuation (NAV) of $23M (4x growth since early 2023) Register Interest   Executive Summary Negev Labs is redefining biotech venture building, advancing safe, non-hallucinogenic neurotherapies targeting cognitive and emotional heal...

  Welcome to our Insights Nesletter! Bitcoin's ETF has surpassed gold's 20-year growth trajectory and is 10 times bigger than mining giant BHP, while a seismic shift in mobility sees Waymo challenging Uber's dominance and Tesla's Cybertaxi threatening to redefine the entire sector. For founders and investors positioned correctly, 2025 could mirror the wealth-creation opportunities of previous market transformations. In this edition, we decode these signals. Inside This Edition: → The Bitcoin Phenomenon:  Why its market cap now challenges the FTSE index → Mobility Revolution:  How Tesla's stock surge predicts ride-sharing's future → The $5.2Bn Commerical Property Playbook:  Inside the zero-loss strategy → Exclusive Founder Insights:  Positioning for 2025's market opportunity A Personal Message to Founders: A Once-in-a-Generation Opportunity Awaits The past few years have tested our resilience and innovation, but they’ve also set the stage for an extraordinary...